Vertex Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
22.01.26
/
50%
€391.10
Target price
22.01.27
€467.05
Performance (%)
-4.14%
Price
17.04.26
€374.90
Summary
This prediction is currently active. With a performance of -4.14%, the BUY prediction for Vertex Pharmaceuticals Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 22.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.739% | 0.739% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€417.90
13.02.26
13.02.26
€455.79
13.02.27
13.02.27
-10.29%
17.04.26
17.04.26
